Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Jan-14 8:22 PM View:  | Fletcher Robert C. V.P., Business Development | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 48,878 | -- | -- | (57%) 86.11K to 37.23K | |
| 28-Jan-14 8:32 PM View: | Pietrusko Robert VP, Regulatory & Quality | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 48,878 | -- | -- | (41%) 119.75K to 70.88K | |
| 28-Jan-14 8:37 PM View: | Soland Daniel B VP, Chief Operating Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 65,818 | -- | -- | 43% 153.33K to 219.15K | |
| 28-Jan-14 9:02 PM View: | Brooke Paul A Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 128,314 | $50.00 | $6,415,700.00 | (100%) 128.31K to 0 | < 1% |
| 28-Jan-14 8:29 PM View: | Milano Vincent President and CEO Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 311,798 | -- | -- | (39%) 794.08K to 482.28K | |
| 28-Jan-14 8:26 PM View: | Kirby John J. V.P., Chief Accounting Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 1,980 | -- | -- | 3300% 60 to 2.04K | |
| 28-Jan-14 8:58 PM View: | Wolf John Peter III VP, General Counsel | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 48,878 | -- | -- | (31%) 159.65K to 110.77K | |
| 28-Jan-14 9:09 PM View: | Glaser Robert Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 45,860 | $50.00 | $2,293,000.00 | (100%) 45.86K to 0 | < 1% |
| 28-Jan-14 9:11 PM View: | Leone John R Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 11,000 | $50.00 | $550,000.00 | (100%) 11.0K to 0 | < 1% |
| 28-Jan-14 9:23 PM View: | Pien Howard H Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 9,000 | $50.00 | $450,000.00 | (100%) 9.0K to 0 | < 1% |
| 28-Jan-14 8:29 PM View: | Milano Vincent President and CEO Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 482,281 | $50.00 | $24,114,000.00 | (100%) 482.28K to 0 | < 1% |
| 28-Jan-14 8:18 PM View: | Doyle Thomas F VP Strategic Initiatives | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 48,878 | -- | -- | 44% 112.09K to 160.97K | |
| 28-Jan-14 8:37 PM View: | Soland Daniel B VP, Chief Operating Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 65,818 | -- | -- | (30%) 219.15K to 153.33K | |
| 28-Jan-14 8:22 PM View: | Fletcher Robert C. V.P., Business Development | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 37,227 | $50.00 | $1,861,350.00 | (100%) 37.23K to 0 | < 1% |
| 28-Jan-14 8:14 PM View: | Broom Colin Md VP & Chief Scientific Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 48,878 | -- | -- | 32% 154.06K to 202.94K | |
| 28-Jan-14 8:14 PM View: | Broom Colin Md VP & Chief Scientific Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 154,058 | $50.00 | $7,702,900.00 | (100%) 154.06K to 0 | < 1% |
| 28-Jan-14 8:18 PM View: | Doyle Thomas F VP Strategic Initiatives | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 112,089 | $50.00 | $5,604,450.00 | (100%) 112.09K to 0 | < 1% |
| 28-Jan-14 8:35 PM View: | Rowland Charles A Jr VP, Chief Financial Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 87,026 | $50.00 | $4,351,300.00 | (100%) 87.03K to 0 | < 1% |
| 28-Jan-14 8:26 PM View: | Kirby John J. V.P., Chief Accounting Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 1,980 | -- | -- | (97%) 2.04K to 60 | |
| 28-Jan-14 8:32 PM View: | Pietrusko Robert VP, Regulatory & Quality | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 70,877 | $50.00 | $3,543,850.00 | (100%) 70.88K to 0 | < 1% |
| 28-Jan-14 9:05 PM View: | Dougherty Michael R Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 20,812 | $50.00 | $1,040,600.00 | (100%) 20.81K to 0 | < 1% |
| 28-Jan-14 8:35 PM View: | Rowland Charles A Jr VP, Chief Financial Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 48,878 | -- | -- | 56% 87.03K to 135.9K | |
| 28-Jan-14 8:22 PM View: | Fletcher Robert C. V.P., Business Development | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 48,878 | -- | -- | 131% 37.23K to 86.11K | |
| 28-Jan-14 8:32 PM View: | Pietrusko Robert VP, Regulatory & Quality | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 48,878 | -- | -- | 69% 70.88K to 119.75K | |
| 28-Jan-14 8:18 PM View: | Doyle Thomas F VP Strategic Initiatives | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 48,878 | -- | -- | (30%) 160.97K to 112.09K | |
| 28-Jan-14 8:14 PM View: | Broom Colin Md VP & Chief Scientific Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 48,878 | -- | -- | (24%) 202.94K to 154.06K | |
| 28-Jan-14 8:29 PM View: | Milano Vincent President and CEO Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 311,798 | -- | -- | 65% 482.28K to 794.08K | |
| 28-Jan-14 9:13 PM View: | McHugh Julie Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 8,666 | $50.00 | $433,300.00 | (100%) 8.67K to 0 | < 1% |
| 28-Jan-14 8:26 PM View: | Kirby John J. V.P., Chief Accounting Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 60 | $50.00 | $3,000.00 | (100%) 60 to 0 | < 1% |
| 28-Jan-14 9:16 PM View: | Claypool William D Md Director | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 49,000 | $50.00 | $2,450,000.00 | (100%) 49.0K to 0 | < 1% |
| 28-Jan-14 8:37 PM View: | Soland Daniel B VP, Chief Operating Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 153,332 | $50.00 | $7,666,600.00 | (100%) 153.33K to 0 | < 1% |
| 28-Jan-14 8:58 PM View: | Wolf John Peter III VP, General Counsel | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 48,878 | -- | -- | 44% 110.77K to 159.65K | |
| 28-Jan-14 8:35 PM View: | Rowland Charles A Jr VP, Chief Financial Officer | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 48,878 | -- | -- | (36%) 135.9K to 87.03K | |
| 28-Jan-14 8:58 PM View: | Wolf John Peter III VP, General Counsel | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 110,768 | $50.00 | $5,538,400.00 | (100%) 110.77K to 0 | < 1% |
| 22-Jan-14 5:04 PM View: | Doyle Thomas F VP Strategic Initiatives | ViroPharma Inc. (VPHM) | 21-Jan-14 | Option Exercise | 59,645 | $10.53 | $627,870.00 | 114% 52.44K to 112.09K | |
| 21-Jan-14 11:44 AM View: | Wolf John Peter III VP, General Counsel | ViroPharma Inc. (VPHM) | 17-Jan-14 | Option Exercise | 69,785 | $11.39 | $794,817.00 | 170% 40.98K to 110.77K | |
| 21-Jan-14 11:41 AM View: | Milano Vincent President and CEO Director | ViroPharma Inc. (VPHM) | 17-Jan-14 | Option Exercise | 79,126 | $8.67 | $686,214.00 | 20% 403.15K to 482.28K | |
| 10-Jan-14 1:33 PM View: | Pietrusko Robert VP, Regulatory & Quality | ViroPharma Inc. (VPHM) | 08-Jan-14 | Payment of Exercise | 11,488 | $49.80 | $572,102.00 | (14%) 82.36K to 70.88K | (< 1%) |
| 10-Jan-14 1:31 PM View: | Broom Colin Md VP & Chief Scientific Officer | ViroPharma Inc. (VPHM) | 08-Jan-14 | Payment of Exercise | 20,140 | $49.80 | $1,002,970.00 | (12%) 174.2K to 154.06K | (< 1%) |
| 10-Jan-14 1:33 PM View: | Pietrusko Robert VP, Regulatory & Quality | ViroPharma Inc. (VPHM) | 08-Jan-14 | Option Exercise | 45,837 | $10.87 | $498,154.00 | 125% 36.53K to 82.36K | |
| 10-Jan-14 1:35 PM View: | Soland Daniel B VP, Chief Operating Officer | ViroPharma Inc. (VPHM) | 08-Jan-14 | Option Exercise | 19,289 | $9.45 | $182,222.00 | 14% 138.35K to 157.64K | |
| 10-Jan-14 1:34 PM View: | Rowland Charles A Jr VP, Chief Financial Officer | ViroPharma Inc. (VPHM) | 08-Jan-14 | Payment of Exercise | 6,449 | $49.80 | $321,160.00 | (7%) 93.47K to 87.03K | (< 1%) |
| 10-Jan-14 1:34 PM View: | Rowland Charles A Jr VP, Chief Financial Officer | ViroPharma Inc. (VPHM) | 08-Jan-14 | Option Exercise | 28,753 | $9.50 | $273,157.00 | 44% 64.72K to 93.47K | |
| 10-Jan-14 1:31 PM View: | Broom Colin Md VP & Chief Scientific Officer | ViroPharma Inc. (VPHM) | 08-Jan-14 | Option Exercise | 142,142 | $5.21 | $740,574.00 | 443% 32.06K to 174.2K | |
| 10-Jan-14 1:35 PM View: | Soland Daniel B VP, Chief Operating Officer | ViroPharma Inc. (VPHM) | 08-Jan-14 | Payment of Exercise | 4,307 | $49.80 | $214,489.00 | (3%) 157.64K to 153.33K | (< 1%) |
| 08-Jan-14 11:08 AM View: | Brooke Paul A Director | ViroPharma Inc. (VPHM) | 07-Jan-14 | Option Exercise | 10,000 | $3.42 | $34,200.00 | 8% 119.0K to 129.0K | |
| 08-Jan-14 11:08 AM View: | Brooke Paul A Director | ViroPharma Inc. (VPHM) | 07-Jan-14 | Payment of Exercise | 686 | $49.89 | $34,224.50 | (< 1%) 129.0K to 128.31K | (< 1%) |
| 07-Jan-14 4:08 PM View: | Milano Vincent President and CEO Director | ViroPharma Inc. (VPHM) | 06-Jan-14 | Option Exercise | 40,309 | $3.55 | $143,097.00 | 11% 362.85K to 403.15K | |
| 03-Jan-14 4:06 PM View: | McHugh Julie Director | ViroPharma Inc. (VPHM) | 03-Jan-14 | Grant | 2,083 | -- | -- | 32% 6.58K to 8.67K | |
| 31-Dec-13 4:33 PM View: | Rowland Charles A Jr VP, Chief Financial Officer | ViroPharma Inc. (VPHM) | 27-Dec-13 | Option Exercise | 4,540 | $5.91 | $26,831.40 | 7% 60.89K to 65.43K |
